呼气末二氧化碳分压对主动腹部按压-减压心肺复苏效果的预测价值及血清S100B蛋白对脑功能的预测价值
该研究纳入2014年9月至2017年12月南方医科大学附属郑州人民医院142例接受主动腹部按压-减压心肺复苏(AACD-CPR)的院内心脏骤停成年患者,按是否恢复自主循环分为成功组与失败组,成功组再按复苏后1个月格拉斯哥-匹兹堡脑功能表现分级(CPC)分为预后良好组(CPC 1-2)与预后不良组(CPC 3-5)。结果显示,心肺复苏20分钟时PETCO2预测复苏成功的AUC为0.969(95%CI 0.943-0.995,P=0.000),临界值24.25 mmHg时敏感度90.7%、特异度96.6%;复苏后3小时血清S100B蛋白预测脑功能预后的AUC为0.925(95%CI 0.867-0.984,P=0.000),临界值1.215 μg/L时敏感度85.2%、特异度85.5%。作者认为PETCO2变化可作为预测AACD-CPR成功的客观指标,血清S100B蛋白可作为预测AACD-CPR后脑功能的客观临床指标。
要点
- 142例院内心脏骤停行AACD-CPR患者中,心肺复苏20分钟时PETCO2预测复苏成功的AUC为0.969(95%CI 0.943-0.995,P=0.000),临界值24.25 mmHg时敏感度90.7%、特异度96.6%。
- 成功组PETCO2在AACD-CPR过程中逐渐升至20 mmHg以上,失败组在2-5分钟内轻微升高后逐渐降至20 mmHg以下,两组各时间点PETCO2差异有统计学意义。
- 复苏后3小时血清S100B蛋白预测脑功能预后的AUC为0.925(95%CI 0.867-0.984,P=0.000),临界值1.215 μg/L时敏感度85.2%、特异度85.5%。
- 预后不良组S100B蛋白在复苏后3-6小时内达峰后逐渐下降,复苏后72小时仍高于正常对照组;预后良好组逐渐下降并于复苏后72小时内恢复至正常对照组水平。
- 按传统定性指标(大动脉搏动、口唇及四肢红润、胸廓自主起伏、瞳孔缩小、存在浅反射等)判断142例中54例复苏成功,按PETCO2指导判断57例复苏成功,两种方法差异无统计学意义(χ²=0.133,P=0.715)。
适用人群与场景
- 2014年9月至2017年12月南方医科大学附属郑州人民医院收治的142例院内心脏骤停并接受AACD-CPR的成年患者。
- 以25名健康受试者作为血清S100B蛋白正常参考值。
诊断标准与关键阈值
- 按是否恢复自主循环(ROSC)分为复苏成功组与失败组。
- 复苏成功组按ROSC后1个月格拉斯哥-匹兹堡脑功能表现分级(CPC)分为预后良好组(CPC 1-2)与预后不良组(CPC 3-5)。
- PETCO2预测复苏成功的临界值为24.25 mmHg(心肺复苏20分钟时)。
- 血清S100B蛋白预测脑功能预后的临界值为1.215 μg/L(ROSC后3小时)。
研究设计与关键结果
- 研究类型为单中心临床研究,纳入142例院内心脏骤停接受AACD-CPR的成年患者,比较复苏成功组与失败组、预后良好组与预后不良组的血流动力学、动脉血气、PETCO2及血清S100B蛋白变化。
- 按传统定性指标142例中54例复苏成功,按PETCO2指导57例复苏成功,两组差异无统计学意义(χ²=0.133,P=0.715)。
- AACD-CPR过程中142例患者动脉血氧分压(PaO2)、动脉血二氧化碳分压(PaCO2)均不同程度改善;ROSC后20分钟心率(HR)、平均动脉压(MAP)、PaO2、PaCO2进一步改善。
- AACD-CPR开始时两组PETCO2均约10 mmHg(1 mmHg=0.133 kPa);成功组PETCO2逐渐升至20 mmHg以上,失败组2-5分钟内轻微升高后逐渐降至20 mmHg以下,两组各时间点差异有统计学意义。
- 心肺复苏20分钟时PETCO2预测复苏成功的AUC为0.969(95%CI 0.943-0.995,P=0.000),临界值24.25 mmHg时敏感度90.7%、特异度96.6%。
- ROSC后0.5小时预后良好组与预后不良组血清S100B蛋白均显著高于正常对照组,预后不良组与预后良好组之间差异无统计学意义。
- 预后不良组S100B蛋白ROSC后3-6小时内达峰后逐渐下降,ROSC后72小时仍高于正常对照组;预后良好组逐渐下降并于ROSC后72小时内恢复至正常对照组水平。
- ROSC后3小时血清S100B蛋白预测脑功能预后的AUC为0.925(95%CI 0.867-0.984,P=0.000),临界值1.215 μg/L时敏感度85.2%、特异度85.5%。
证据类型、等级与局限
- 证据类型:单中心临床研究。
- 作者结论:PETCO2变化可作为预测AACD-CPR成功的客观指标,血清S100B蛋白可作为预测AACD-CPR后脑功能的客观临床指标,两者对临床治疗有一定参考和指导意义。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,PETCO2变化可作为预测AACD-CPR复苏成功的客观指标,血清S100B蛋白可作为预测AACD-CPR后脑功能的客观临床指标,两者对临床治疗有一定参考和指导意义。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVE: To explore the predictive value of partial pressure of end-tidal carbon dioxide (PETCO2) on the effect of active abdominal compression-decompression cardiopulmonary resuscitation (AACD-CPR) and serum S100B protein on cerebral function.
METHODS: 142 adult patients with in-hospital cardiac arrest (IHCA) AACD-CPR in Zhengzhou People's Hospital, Affiliated Southern Medical University from September 2014 to December 2017 were enrolled. Patients were divided into successful group and failure group according to restoration of spontaneous circulation (ROSC) or not; and then according to Glasgow-Pittsburgh cerebral performance categories (CPC) one month after ROSC, the successful group was divided into good prognosis group (CPC 1-2) and poor prognosis group (CPC 3-5) further. The variations of hemodynamic, arterial blood gas index, PETCO2 and serum S100B protein level (25 healthy subjects as normal S100B protein level reference value) during the recovery were analyzed. The predictive value of PETCO2 on the effect of AACD-CPR and serum S100B protein on cerebral function of successful resuscitation patients were analyzed by receiver operating characteristic curve (ROC).
RESULTS: (1) According to the traditional qualitative indexes, such as pulsation of the large artery, redness of lips and extremities, spontaneous fluctuation of chest, narrowing of pupil, existence of shallow reflex, etc, 54 in 142 patients with IHCA were successfully resuscitated; 57 cases were successfully resuscitated through the guidance of PETCO2, there was no significant difference between the two groups (χ2 = 0.133, P = 0.715). With the AACD-CPR, 142 CA patients' arterial partial pressure of oxygen (PaO2), arterial blood carbon dioxide partial pressure (PaCO2) were all improved with different degrees; heart rate (HR), mean arterial pressure (MAP), PaO2 and PaCO2 were further improved at 20 minutes after ROSC. At beginning of AACD-CPR, PETCO2 of both groups were about 10 mmHg (1 mmHg = 0.133 kPa). PETCO2 was gradually rising to above 20 mmHg in successful group during AACD-CPR process; the failed group increased slightly within 2-5 minutes, then gradually decreased to below 20 mmHg, there was a significant difference in PETCO2 between the two groups at each time. The area under the ROC (AUC) of PETCO2 at CPR 20 minutes in predicting the outcome of the resuscitation was 0.969, 95% confidence interval (95%CI) was 0.943-0.995 (P = 0.000), when the cut-off value of PETCO2 was 24.25 mmHg, the sensitivity was 90.7%, and the specificity was 96.6%. (2) The level of serum S100B protein at 0.5 hour after ROSC in the good prognosis group and the poor prognosis group were significant higher than that of the normal control group; there was no significant difference between poor prognosis group and good prognosis group. S100B protein concentration of the poor prognosis group reached the peak within 3-6 hours, then gradually decreased, and was higher than that of the normal control group at ROSC 72 hours; the good prognosis was gradually decreased and recovered to normal control group within ROSC 72 hours. The AUC of S100B at 3 hours after ROSC on cerebral function prognosis prediction was 0.925, 95%CI was 0.867-0.984 (P = 0.000), when the cut-off value of S100B protein was 1.215 μg/L, the sensitivity was 85.2%, and the specificity was 85.5%.
CONCLUSIONS: The variation of PETCO2 can be used as an objective index to predict the success of AACD-CPR, and serum S100B protein can be used as an objective clinical index to predict cerebral function after AACD-CPR, both of which have some reference and guiding significance for clinical treatment.
参考来源
- Wang H, Sha X, Zhang S, et al. [Predictive value of partial pressure of end-tidal carbon dioxide on the effect of active abdominal compression-decompression cardiopulmonary resuscitation and serum S100B protein on cerebral function]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2018. PMID: 29402359. doi:10.3760/cma.j.issn.2095-4352.2018.02.005
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。